Argus restated their buy rating on shares of Dow Chemical (NYSE:DOW) in a report released on Friday, Stock Ratings News reports. Argus currently has a $47.00 price objective on the stock.
Dow Chemical (NYSE:DOW) opened at 39.11 on Friday. Dow Chemical has a 52-week low of $27.45 and a 52-week high of $40.24. The stock’s 50-day moving average is $37.34 and its 200-day moving average is $34.25. The company has a market cap of $46.439 billion and a P/E ratio of 16.79.
Dow Chemical (NYSE:DOW) last posted its quarterly earnings results on Thursday, October 24th. The company reported $0.50 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.54 by $0.04. The company had revenue of $13.73 million for the quarter, compared to the consensus estimate of $14.00 million. During the same quarter last year, the company posted $0.42 earnings per share. Dow Chemical’s revenue was up .7% compared to the same quarter last year. On average, analysts predict that Dow Chemical will post $2.32 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank raised their price target on shares of Dow Chemical from $37.00 to $43.00 in a research note to investors on Friday. They now have a hold rating on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Dow Chemical from $39.00 to $45.00 in a research note to investors on Thursday, October 3rd. They now have an outperform rating on the stock. Finally, analysts at UBS AG raised their price target on shares of Dow Chemical from $42.00 to $43.00 in a research note to investors on Tuesday, October 1st. They now have a buy rating on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company’s stock. Dow Chemical presently has a consensus rating of Hold and a consensus price target of $39.67.
The Dow Chemical Company combines the power of science and technology to passionately innovate what is essential to human progress.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.